Skip to main content
Tessa NewsLink
Paste a health news link, or browse
Latest checks

Source study found

Story checked

A Natural Compound Found in Everyday Foods Shows Surprising Power Against Lung Cancer (opens in a new tab)

scitechdaily.com · 2026-10-31

Short answerEvidenceSource

Short answer

Mixed

Mixed.

The claims we could check match the study, but some claims were not covered by the evidence reviewed.

  • 2 supported
  • 3 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Mixed

Every claim we could check holds up. Two of five claims match the study. This overall rating is based only on the claims we could check. Three claims the study doesn't address.

  • 2 supported
  • 3 not covered
Open claim evidence
3
Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

5 claims in this story

Showing all 5 claimsChoose a verdict to focus the list.

Claim 1 of 5Not coveredQuercetin, a compound found in citrus fruits, onions, and buckwheat, slowed lung cancer cell division and movement in laboratory experiments, and at the highest dose tested cell migration nearly stopped.View evidenceHide evidence

As statedAt the highest dose tested, cell migration nearly stopped.

Why this verdict

The abstract-level profile supports that quercetin reduced proliferation/cell-cycle progression and suppressed migration in A549 and H520 lung cancer cell lines. However, it does not provide quantitative migration results, dose levels, or the stated magnitude that migration 'nearly stopped' at the highest dose. The specific food-source framing—citrus fruits, onions, and buckwheat—is also not present in the supplied paper profile.

1

Study evidence

Quercetin induced tumor cell cycle arrest via the p53–p21 axis in both A549 and H520 human lung cancer cell lines; associated with upregulation of CDKN1A and downregulation of CDK1.

“Quercetin induced tumor cell cycle arrest via the p53-p21 axis and suppressed tumor cell migration in both the A549 and H520 human lung cancer cell lines.”
Claim 2 of 5Not coveredResearchers at Universitätsklinikum Erlangen at Friedrich-Alexander Universität Erlangen-Nürnberg studied quercetin in lung cancer cell lines, mouse lung tissue sections, and living mice, and the paper appeared in Cell Death Discovery.View evidenceHide evidence

Why this verdict

The profile supports that the study included human lung cancer cell lines and in vivo murine experiments, plus ex vivo and systemic immune/microbiome modules. But the supplied abstract-level profile does not verify the researchers' institutional affiliation, the journal name, or the specific claim that mouse lung tissue sections were studied. Those bibliographic and methodological specifics cannot be confirmed from the supplied profile.

1

Study evidence

Quercetin induced tumor cell cycle arrest via the p53–p21 axis in both A549 and H520 human lung cancer cell lines; associated with upregulation of CDKN1A and downregulation of CDK1.

“Quercetin induced tumor cell cycle arrest via the p53-p21 axis and suppressed tumor cell migration in both the A549 and H520 human lung cancer cell lines.”
2

Study evidence

Quercetin decreased tumor load in a murine lung tumor model without affecting body weight.

“In an in vivo model, quercetin decreased the tumor load without affecting the body weight.”
Claim 3 of 5Not coveredIn mouse lung tissue sections, quercetin increased interferon-alpha-2, changed the gut microbiome, and was associated with fewer tumor sites, although the article says only a few animals developed tumors so that finding is not confirmed.View evidenceHide evidence

As statedOnly a few animals developed tumors, leaving too little evidence to confirm that finding.

Why this verdict

The profile supports related findings: IFN-α2 induction in an ex vivo model, gut microbiome shifts toward SCFA-producing bacteria in vivo, and decreased tumor load in a murine model. However, the supplied abstract-level profile does not verify that these occurred specifically in mouse lung tissue sections, does not state 'fewer tumor sites' as the measured outcome, and does not include the article's caveat that only a few animals developed tumors. The broad direction is aligned, but the specific framing is not confirmable at this evidence depth.

1

Study evidence

Quercetin decreased tumor load in a murine lung tumor model without affecting body weight.

“In an in vivo model, quercetin decreased the tumor load without affecting the body weight.”
2

Study evidence

Quercetin treatment in an ex vivo model resulted in induction/increased production of interferon alpha-2 (IFN-α2), described as an anti-tumor cytokine.

“In the ex vivo model, quercetin treatment resulted in the induction of interferon alpha-2 (IFN-α2), a well-known anti-tumor cytokine.”
Claim 4 of 5SupportedThe story says quercetin affected several cancer-related processes, including lowering oxidative stress in one cell type and reducing EGFR and PD-L1 levels in the cancer cells studied.View evidenceHide evidence

Why this verdict

The abstract-level profile supports that quercetin affected multiple cancer-related processes in vitro: it reduced oxidative stress and downregulated EGFR and PD-L1, explicitly in a dose-response manner on A549 cell surfaces. The claim is appropriately preclinical and mechanistic, though the evidence should be read as strongest for A549 for EGFR/PD-L1 rather than all lung cancer cell lines.

1

Study evidence

Quercetin induced tumor cell cycle arrest via the p53–p21 axis in both A549 and H520 human lung cancer cell lines; associated with upregulation of CDKN1A and downregulation of CDK1.

“Quercetin induced tumor cell cycle arrest via the p53-p21 axis and suppressed tumor cell migration in both the A549 and H520 human lung cancer cell lines.”
Claim 5 of 5SupportedThe article cautions that the experiments do not establish whether the effects extend to people or whether eating quercetin-containing foods would reproduce the results.View evidenceHide evidence

Why this verdict

The supplied profile describes only preclinical systems: cultured human lung cancer cell lines, murine in vivo models, ex vivo assays, microbiome profiling, and mouse immune transcriptomics. It contains no human trial or dietary-intervention evidence, so the story's caution that the findings do not establish effects in people or effects from eating quercetin-containing foods is consistent with the paper profile.

1

Study evidence

Quercetin induced tumor cell cycle arrest via the p53–p21 axis in both A549 and H520 human lung cancer cell lines; associated with upregulation of CDKN1A and downregulation of CDK1.

“Quercetin induced tumor cell cycle arrest via the p53-p21 axis and suppressed tumor cell migration in both the A549 and H520 human lung cancer cell lines.”
2

Study evidence

Quercetin decreased tumor load in a murine lung tumor model without affecting body weight.

“In an in vivo model, quercetin decreased the tumor load without affecting the body weight.”
Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

  • The profile limits EGFR and PD-L1 downregulation most clearly to A549 surface expression; broader generalization to all studied cell lines is not supported by the abstract.

    The story does not clearly convey this cell-line-specific limitation, which matters for interpreting how broadly the marker findings apply.

    From in vitro cell-line experiments

  • The in vivo profile reports no body-weight effect as a tolerability signal.

    The story presentation does not mention the paper's abstract-level statement that tumor-load reduction occurred without affecting body weight.

    From in vivo murine tumor model (treatment study)

  • Quercetin reprogrammed the splenic CD8+ T-cell transcriptome, including Ltf upregulation and downregulation of several oncogene-associated transcripts.

    The story broadly refers to immune signals but does not specifically reflect the splenic CD8+ T-cell transcriptome result, which is a distinct material paper element.

    From in vivo CD8+ T‑cell transcriptome profiling

6 things the story did carry across
  • In vitro quercetin treatment reduced proliferation/cell-cycle progression and migration in human lung cancer cell lines A549 and H520.
  • Quercetin reduced oxidative stress and downregulated EGFR and PD-L1, with EGFR/PD-L1 surface downregulation explicitly reported for A549 cells in dose-response fashion.
  • In vivo quercetin treatment decreased tumor load in a murine lung tumor model.
  • Ex vivo quercetin treatment induced or increased IFN-α2, described as an anti-tumor cytokine.
  • In vivo quercetin exposure shifted the gut microbiome toward increased abundance of SCFA-producing bacteria.
  • The findings are preclinical and do not establish efficacy, safety, or dietary reproducibility in humans.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

5

Evidence read

study summary

Lead result

in vitro

1Lead resultin vitroQuercetin has direct anti-tumor effects on lung cancer cells by regulating cell-cycle pathways (p53–p21/CDKN1A; CDK1), reducing oxidative stress, and suppressing migration while downregulating oncogenic surface markers (EGFR, PD-L1, Ki67).in vitro cell-line experimentsExpand

In plain English

In vitro treatment of human lung cancer cell lines (A549, H520) with quercetin induced cell-cycle arrest via the p53–p21/CDKN1A axis (with reported CDK1 downregulation), reduced proliferation and migration, decreased oxidative stress, and downregulated oncogenic surface proteins EGFR and PD-L1 (reported dose-response on A549); Ki67 reduction was also reported in the paper's mechanistic summary.

Key findings

  • Quercetin induced tumor cell cycle arrest via the p53–p21 axis in both A549 and H520 human lung cancer cell lines; associated with upregulation of CDKN1A and downregulation of CDK1.
  • Quercetin significantly attenuated proliferation of tumor cells and decreased Ki67 expression.
“Quercetin induced tumor cell cycle arrest via the p53-p21 axis and suppressed tumor cell migration in both the A549 and H520 human lung cancer cell lines.”
What this piece can’t prove
  • Surface marker downregulation (EGFR, PD-L1) is explicitly reported for A549 only; broader generalization to other cell lines is not supported by the abstract text.

2 further details could not be confirmed from the summary.

2in vivo animalIn vivo quercetin treatment reduces lung tumor burden without overt toxicity and is associated with tumor/immune pathway modulation (including CDKN1A/CDK1 changes) in a murine model.in vivo murine tumor model (treatment study)Expand

In plain English

Abstract reports that in a murine lung tumor model, quercetin treatment decreased tumor load without affecting body weight and was associated with modulation of tumor and immune pathways: upregulation of CDKN1A and downregulation of CDK1 (reported for murine models), decreases in Ki67, EGFR, and PD-L1 expression (reported overall), and reprogramming of splenic CD8+ T cell transcriptome (e.g., increased Ltf and decreased several oncogene transcripts). The abstract does not provide doses, sample sizes, statistical measures, or detailed assay methods for the in vivo experiments.

Key findings

  • Quercetin decreased tumor load in a murine lung tumor model without affecting body weight.
  • Quercetin treatment was associated with upregulation of CDKN1A and downregulation of CDK1 in murine models.
“In an in vivo model, quercetin decreased the tumor load without affecting the body weight.”
What this piece can’t prove
  • Assay methods and whether biomarker changes (e.g., EGFR, PD-L1, Ki67) were measured directly in tumor tissue in vivo versus inferred from other models are not specified.

3 further details could not be confirmed from the summary.

3ex vivo animalQuercetin exerts immunoregulatory effects ex vivo, including induction of the anti-tumor cytokine IFN-α2.Ex vivo cytokine induction assayExpand

In plain English

In an ex vivo model, quercetin treatment was reported to induce/interrogate an increase in interferon alpha-2 (IFN-α2) production, described by the authors as an anti-tumor cytokine, consistent with an immunoregulatory effect of quercetin.

Key findings

  • Quercetin treatment in an ex vivo model resulted in induction/increased production of interferon alpha-2 (IFN-α2), described as an anti-tumor cytokine.
“In the ex vivo model, quercetin treatment resulted in the induction of interferon alpha-2 (IFN-α2), a well-known anti-tumor cytokine.”
What this piece can’t prove

3 further details could not be confirmed from the summary.

4in vivo animalQuercetin conditions systemic/immune biology in vivo, including gut microbiome shifts toward SCFA-producing taxa and reprogramming of splenic CD8+ T-cell transcriptome (e.g., Ltf up; multiple oncogenes down).in vivo animal microbiome profilingExpand

In plain English

The abstract reports that, in vivo, quercetin "conditioned the gut microbiome, promoting an increased abundance of SCFA-producing bacteria."

Key findings

  • Quercetin conditioned the gut microbiome, promoting an increased abundance of SCFA-producing bacteria (abstract statement).
“It also conditioned the gut microbiome, promoting an increased abundance of SCFA-producing bacteria.”
What this piece can’t prove
  • Unclear whether microbiome changes were causal, correlated with other measured outcomes, or assessed in the same animal cohort as other in vivo endpoints.

2 further details could not be confirmed from the summary.

5in vivo animalQuercetin conditions systemic/immune biology in vivo, including gut microbiome shifts toward SCFA-producing taxa and reprogramming of splenic CD8+ T-cell transcriptome (e.g., Ltf up; multiple oncogenes down).in vivo CD8+ T‑cell transcriptome profilingExpand

In plain English

In vivo quercetin exposure was reported to reprogram the splenic CD8+ T‑cell transcriptome, with upregulation of the tumor suppressor Ltf and downregulation of multiple genes described as oncogenes or linked to proliferation/metastasis (POU6F1, Celsr1, ST3GAL6, Sik2, Adnp, Jun) (abstract).

Key findings

  • Quercetin reprogrammed the splenic CD8+ T‑cell transcriptome, notably upregulating Ltf and downregulating POU6F1, Celsr1, ST3GAL6, Sik2, Adnp, and Jun (abstract).
“Quercetin also reprogrammed the splenic CD8 + T cell transcriptome, most notably by upregulating the tumor suppressor gene Ltf while also downregulating several oncogenes involved in proliferation and metastasis, namely POU6F1, Celsr1, ST3GAL6, Sik2, Adnp, and Jun.”
What this piece can’t prove

3 further details could not be confirmed from the summary.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Papers considered

The selected paper, plus nearby candidates.

PubMed, Europe PMC, Crossref · 37 candidate papers

And 31 more candidates considered.